AG-013736
A4061027
Phase 2 small_molecule completed
Quick answer
AG-013736 for Thyroid Neoplasms is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Thyroid Neoplasms
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed